Literature DB >> 182074

Microtiter assay for interferon: microspectrophotometric quantitation of cytopathic effect.

N H McManus.   

Abstract

This report describes an accurate, reproducible, and efficient microassay for human interferon, using a dye-uptake method to quantitate cytopathogenicity. The antiviral activity was measured by using a Gilford 300-N microsepctrophotometer, with the automatic programmer, sampler, and data lister. Two hundred interferon samples, each in a final volume of 1.0 ml, may be analyzed and recorded in 45 min. The reproducibility of a laboratory reference interferon and the human international reference B 69/19 on two different cell lines, using the model Q Oxford sampler, was found to be excellent, with the standard error of the log10 geometric mean of both references +/- 0.04 to 0.06.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 182074      PMCID: PMC169714          DOI: 10.1128/aem.31.1.35-38.1976

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  11 in total

1.  Application of a microtechnique to viral serological investigations.

Authors:  J L SEVER
Journal:  J Immunol       Date:  1962-03       Impact factor: 5.422

2.  A micro assay for mouse and human interferon.

Authors:  H Dahl; M Degré
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1972

3.  Dye uptake assay: an efficient and sensitive method for human interferon titration.

Authors:  A L Pidot
Journal:  Appl Microbiol       Date:  1971-10

4.  Semi-micro, dye-binding assay for rabbit interferon.

Authors:  J A Armstrong
Journal:  Appl Microbiol       Date:  1971-04

5.  Minicultures of mammalian cells in a new plastic plate.

Authors:  D A Fuccillo; L W Catalano; F L Moder; D A Debus; J L Sever
Journal:  Appl Microbiol       Date:  1969-04

6.  Influence of mixing on dilutions obtained with the microtiter technique.

Authors:  A Sassen; F Kennes
Journal:  J Immunol Methods       Date:  1972-05       Impact factor: 2.303

7.  Piggy-back microtransfer technique.

Authors:  L W Catalano; D A Fuccillo; J L Sever
Journal:  Appl Microbiol       Date:  1969-12

8.  Microdilution antibiotic susceptibility test: examination of certain variables.

Authors:  R C Tilton; L Lieberman; E H Gerlach
Journal:  Appl Microbiol       Date:  1973-11

9.  Interferon production by human cells in vitro.

Authors:  C A Spin; R S Chang; L Mishra; H D Golden
Journal:  Appl Microbiol       Date:  1972-11

10.  Nonspecific adsorption of proteins to microplates.

Authors:  S Inouye
Journal:  Appl Microbiol       Date:  1973-02
View more
  12 in total

1.  Assay of human interferon in Vero cells by several methods.

Authors:  P C Ferreira; M L Peixoto; M A Silva; R R Golgher
Journal:  J Clin Microbiol       Date:  1979-04       Impact factor: 5.948

Review 2.  Clinical pharmacokinetics of interferons.

Authors:  R J Wills
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

3.  Transport of biologically active interferon-gamma across human skin in vitro.

Authors:  S M Short; W Rubas; B D Paasch; R J Mrsny
Journal:  Pharm Res       Date:  1995-08       Impact factor: 4.200

4.  Application of an objective biological assay of human interferons to clinical specimens and a survey of a normal population.

Authors:  R L Forti; R A Moldovan; W M Mitchell; P Callicoat; S S Schuffman; H A Davies; D M Smith
Journal:  J Clin Microbiol       Date:  1985-05       Impact factor: 5.948

5.  Cloning and expression of the cDNA for the murine interferon gamma receptor.

Authors:  P W Gray; S Leong; E H Fennie; M A Farrar; J T Pingel; J Fernandez-Luna; R D Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

6.  Inhibitory effects of recombinant manganese superoxide dismutase on influenza virus infections in mice.

Authors:  R W Sidwell; J H Huffman; K W Bailey; M H Wong; A Nimrod; A Panet
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

7.  Comparative activities of selected combinations of acyclovir, vidarabine, arabinosyl hypoxanthine, interferon, and polyriboinosinic acid-polyribocytidylic acid complex against herpes simplex virus type 2 in tissue culture and intravaginally inoculated mice.

Authors:  L R Crane; D A Milne; J C Sunstrum; A M Lerner
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

8.  Automated, quantitative cytopathic effect reduction assay for interferon.

Authors:  T J Yeh; P T McBride; J C Overall; J A Green
Journal:  J Clin Microbiol       Date:  1982-08       Impact factor: 5.948

9.  PSI-7851, a pronucleotide of beta-D-2'-deoxy-2'-fluoro-2'-C-methyluridine monophosphate, is a potent and pan-genotype inhibitor of hepatitis C virus replication.

Authors:  Angela M Lam; Eisuke Murakami; Christine Espiritu; Holly M Micolochick Steuer; Congrong Niu; Meg Keilman; Haiying Bao; Veronique Zennou; Nigel Bourne; Justin G Julander; John D Morrey; Donald F Smee; David N Frick; Julie A Heck; Peiyuan Wang; Dhanapalan Nagarathnam; Bruce S Ross; Michael J Sofia; Michael J Otto; Phillip A Furman
Journal:  Antimicrob Agents Chemother       Date:  2010-06-01       Impact factor: 5.191

10.  A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo.

Authors:  Craig W Day; Ralph Baric; Sui Xiong Cai; Matt Frieman; Yohichi Kumaki; John D Morrey; Donald F Smee; Dale L Barnard
Journal:  Virology       Date:  2009-10-22       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.